Mersana Therapeutics, Inc (NASDAQ:MSRN) shares have gained about 46% over the past one month. The stock jumped thanks to the broader optimism in the industry after AbbVie (NYSE:ABBV) agreed to acquire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results